Skip to Content
Merck
CN
  • Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indeno[1,2-c]pyridazin-5-one core.

Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indeno[1,2-c]pyridazin-5-one core.

Journal of medicinal chemistry (2006-06-09)
Raphaël Frédérick, Willy Dumont, Frédéric Ooms, Lindsey Aschenbach, Cornelis J Van der Schyf, Neal Castagnoli, Johan Wouters, Alain Krief
ABSTRACT

The synthesis and enzyme inhibitor properties of reversible type B monoamine oxidase inhibitors are described. These compounds belong to the 5H-indeno[1,2-c]pyridazine family and possess a hydrophobic benzyloxy or 4,4,4-trifluorobutoxy side chain which, in contrast to a previous assignment, has been unambiguously located at C(8) of the heterocyclic moiety. Investigation of the regioisomeric structures establishes that substitution of the 5H-indeno[1,2-c]pyridazin-5-one core at C(7) vs C(8) dramatically influences the MAO-inhibiting properties of these compounds.

MATERIALS
Product Number
Brand
Product Description

Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 5 cm × 2.1 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 15 cm × 2.1 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 25 cm × 4.6 mm
Supelco
Discovery® C8 Supelguard Guard Cartridge, 5 μm particle size, L × I.D. 2 cm × 2.1 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 25 cm × 3 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 5 cm × 4.6 mm
Supelco
Discovery® C8 Supelguard Guard Cartridge, 5 μm particle size, L × I.D. 2 cm × 4 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 12.5 cm × 4 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4.6 mm
Supelco
Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 12.5 cm × 4.6 mm
Supelco
Discovery® C8 Supelguard Guard Cartridge, 5 μm particle size, L × I.D. 2 cm × 4 mm